US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist
  • 2.8300
  • -0.1700-5.67%
Close Feb 25 16:00 ET
  • 2.9500
  • +0.1200+4.24%
Post 19:23 ET
3.42MMarket Cap-0.23P/E (TTM)

InMed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
Total revenue
-10.36%1.11M
40.23%1.26M
11.18%4.6M
-44.48%1.28M
13.41%1.17M
163.99%1.24M
181.14%901.86K
279.61%4.14M
348.96%2.31M
233.97%1.03M
Operating revenue
-10.36%1.11M
40.23%1.26M
11.18%4.6M
-44.48%1.28M
13.41%1.17M
163.99%1.24M
181.14%901.86K
279.61%4.14M
348.96%2.31M
233.97%1.03M
Cost of revenue
-28.96%650.81K
-12.42%771.23K
27.97%3.5M
10.30%817K
4.96%883.14K
170.53%916.06K
8.48%880.62K
400.56%2.73M
179.46%740.69K
560.93%841.41K
Gross profit
42.19%460.89K
2,222.82%493.41K
-21.53%1.1M
-70.32%466.07K
50.36%289.46K
147.13%324.14K
104.33%21.24K
158.13%1.4M
528.87%1.57M
5.61%192.51K
Operating expense
31.45%2.67M
-15.04%2.25M
-5.59%9.24M
18.62%2.48M
-10.94%2.09M
-14.22%2.03M
-11.46%2.65M
-31.76%9.78M
-36.71%2.09M
-37.08%2.34M
Selling and administrative expenses
13.90%1.55M
9.49%1.42M
-10.21%5.25M
-13.87%1.21M
-2.73%1.37M
-6.89%1.36M
-16.77%1.3M
-14.85%5.85M
-19.11%1.41M
-26.23%1.41M
-General and administrative expense
13.90%1.55M
9.49%1.42M
-10.21%5.25M
-13.87%1.21M
-2.73%1.37M
-6.89%1.36M
-16.77%1.3M
-14.85%5.85M
-19.11%1.41M
-26.23%1.41M
Research and development costs
73.89%1.06M
-40.32%771.18K
0.88%3.77M
93.41%1.21M
-25.22%656.76K
-28.37%609.79K
-6.28%1.29M
-48.75%3.73M
-58.44%623.74K
-49.91%878.3K
Depreciation amortization depletion
-3.68%53.2K
-0.46%54.58K
8.58%219.6K
2.44%54.77K
8.05%54.77K
12.61%55.23K
11.79%54.83K
8.94%202.25K
-0.97%53.46K
-4.97%50.69K
-Depreciation and amortization
-3.68%53.2K
-0.46%54.58K
8.58%219.6K
2.44%54.77K
8.05%54.77K
12.61%55.23K
11.79%54.83K
8.94%202.25K
-0.97%53.46K
-4.97%50.69K
Operating profit
-29.41%-2.21M
33.16%-1.75M
2.92%-8.13M
-289.14%-2.01M
16.43%-1.8M
23.69%-1.7M
24.57%-2.62M
39.25%-8.38M
83.06%-516.26K
39.28%-2.15M
Net non-operating interest income expense
-292.50%-321.01K
-58.03%57.09K
7.20%527.9K
-30.24%103.64K
-21.89%121.46K
44.01%166.76K
87.42%136.04K
412.48%492.44K
340.81%148.56K
402.19%155.5K
Non-operating interest income
-81.69%30.54K
-58.03%57.09K
7.20%527.9K
-30.24%103.64K
-21.89%121.46K
44.01%166.76K
87.42%136.04K
412.48%492.44K
340.81%148.56K
402.19%155.5K
Non-operating interest expense
--351.55K
----
----
----
----
--0
----
----
----
----
Other net income (expense)
-179.73%-47.75K
139.85%19.31K
-28.53%-61.92K
-181.01%-25.2K
-1,662.02%-48.16K
195.97%59.9K
49.94%-48.46K
99.02%-48.18K
100.64%31.11K
-108.28%-2.73K
Gain on sale of security
-179.73%-47.75K
139.85%19.31K
-28.53%-61.92K
-181.01%-25.2K
-1,662.02%-48.16K
195.97%59.9K
49.94%-48.46K
96.64%-48.18K
102.25%31.11K
-108.28%-2.73K
Income before tax
-74.20%-2.58M
33.86%-1.68M
3.35%-7.67M
-473.57%-1.93M
13.70%-1.72M
29.55%-1.48M
27.59%-2.54M
57.34%-7.93M
95.72%-336.59K
42.56%-2M
Income tax
0
0
-45.80%7.1K
294.44%7.1K
0
0
0
13.1K
1.8K
1.5K
Net income
-74.20%-2.58M
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
Net income continuous Operations
-74.20%-2.58M
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
Minority interest income
Net income attributable to the parent company
-74.20%-2.58M
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-74.20%-2.58M
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
Basic earnings per share
1.89%-3.64
82.22%-2.71
68.92%-20.2
-167.86%-3.8
70.00%-3.6
79.62%-3.71
81.23%-15.24
90.20%-65
102.15%5.6
90.23%-12
Diluted earnings per share
1.89%-3.64
82.22%-2.71
68.92%-20.2
-167.86%-3.8
70.00%-3.6
79.62%-3.71
81.23%-15.24
90.20%-65
102.15%5.6
90.23%-12
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023
Total revenue -10.36%1.11M40.23%1.26M11.18%4.6M-44.48%1.28M13.41%1.17M163.99%1.24M181.14%901.86K279.61%4.14M348.96%2.31M233.97%1.03M
Operating revenue -10.36%1.11M40.23%1.26M11.18%4.6M-44.48%1.28M13.41%1.17M163.99%1.24M181.14%901.86K279.61%4.14M348.96%2.31M233.97%1.03M
Cost of revenue -28.96%650.81K-12.42%771.23K27.97%3.5M10.30%817K4.96%883.14K170.53%916.06K8.48%880.62K400.56%2.73M179.46%740.69K560.93%841.41K
Gross profit 42.19%460.89K2,222.82%493.41K-21.53%1.1M-70.32%466.07K50.36%289.46K147.13%324.14K104.33%21.24K158.13%1.4M528.87%1.57M5.61%192.51K
Operating expense 31.45%2.67M-15.04%2.25M-5.59%9.24M18.62%2.48M-10.94%2.09M-14.22%2.03M-11.46%2.65M-31.76%9.78M-36.71%2.09M-37.08%2.34M
Selling and administrative expenses 13.90%1.55M9.49%1.42M-10.21%5.25M-13.87%1.21M-2.73%1.37M-6.89%1.36M-16.77%1.3M-14.85%5.85M-19.11%1.41M-26.23%1.41M
-General and administrative expense 13.90%1.55M9.49%1.42M-10.21%5.25M-13.87%1.21M-2.73%1.37M-6.89%1.36M-16.77%1.3M-14.85%5.85M-19.11%1.41M-26.23%1.41M
Research and development costs 73.89%1.06M-40.32%771.18K0.88%3.77M93.41%1.21M-25.22%656.76K-28.37%609.79K-6.28%1.29M-48.75%3.73M-58.44%623.74K-49.91%878.3K
Depreciation amortization depletion -3.68%53.2K-0.46%54.58K8.58%219.6K2.44%54.77K8.05%54.77K12.61%55.23K11.79%54.83K8.94%202.25K-0.97%53.46K-4.97%50.69K
-Depreciation and amortization -3.68%53.2K-0.46%54.58K8.58%219.6K2.44%54.77K8.05%54.77K12.61%55.23K11.79%54.83K8.94%202.25K-0.97%53.46K-4.97%50.69K
Operating profit -29.41%-2.21M33.16%-1.75M2.92%-8.13M-289.14%-2.01M16.43%-1.8M23.69%-1.7M24.57%-2.62M39.25%-8.38M83.06%-516.26K39.28%-2.15M
Net non-operating interest income expense -292.50%-321.01K-58.03%57.09K7.20%527.9K-30.24%103.64K-21.89%121.46K44.01%166.76K87.42%136.04K412.48%492.44K340.81%148.56K402.19%155.5K
Non-operating interest income -81.69%30.54K-58.03%57.09K7.20%527.9K-30.24%103.64K-21.89%121.46K44.01%166.76K87.42%136.04K412.48%492.44K340.81%148.56K402.19%155.5K
Non-operating interest expense --351.55K------------------0----------------
Other net income (expense) -179.73%-47.75K139.85%19.31K-28.53%-61.92K-181.01%-25.2K-1,662.02%-48.16K195.97%59.9K49.94%-48.46K99.02%-48.18K100.64%31.11K-108.28%-2.73K
Gain on sale of security -179.73%-47.75K139.85%19.31K-28.53%-61.92K-181.01%-25.2K-1,662.02%-48.16K195.97%59.9K49.94%-48.46K96.64%-48.18K102.25%31.11K-108.28%-2.73K
Income before tax -74.20%-2.58M33.86%-1.68M3.35%-7.67M-473.57%-1.93M13.70%-1.72M29.55%-1.48M27.59%-2.54M57.34%-7.93M95.72%-336.59K42.56%-2M
Income tax 00-45.80%7.1K294.44%7.1K00013.1K1.8K1.5K
Net income -74.20%-2.58M33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M
Net income continuous Operations -74.20%-2.58M33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M
Minority interest income
Net income attributable to the parent company -74.20%-2.58M33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -74.20%-2.58M33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M
Basic earnings per share 1.89%-3.6482.22%-2.7168.92%-20.2-167.86%-3.870.00%-3.679.62%-3.7181.23%-15.2490.20%-65102.15%5.690.23%-12
Diluted earnings per share 1.89%-3.6482.22%-2.7168.92%-20.2-167.86%-3.870.00%-3.679.62%-3.7181.23%-15.2490.20%-65102.15%5.690.23%-12
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Hutchmed (China)
HCM
+2.21%
Enerpac Tool
EPAC
+2.10%
Ermenegildo Zegna NV
ZGN
+1.63%
Lantheus
LNTH
+1.39%
eBay
EBAY
+1.34%

Unlock the Full List